Immunotoxicology of immunomodulators.

Area of Science:

• Immunotoxicology
• Pharmacology
• Drug Safety Evaluation

Background:

• Immunotoxicology traditionally focuses on immunosuppression.
• Toxic effects of immunomodulation are less understood.
• Observed side effects include flu-like symptoms and autoimmune disease exacerbation.

Purpose of the Study:

• To highlight the importance of assessing immunomodulatory drug toxicity.
• To evaluate current preclinical safety assessment protocols for immunomodulators.
• To suggest improvements for preclinical and post-marketing surveillance.

Main Methods:

• Review of existing literature on immunotoxicology and immunomodulation.
• Analysis of reported immunopharmacologically-mediated side-effects.
• Discussion of current preclinical testing in rats and its limitations.

Main Results:

• Immunomodulation can cause adverse effects like hypersensitivity and altered drug metabolism.
• Current preclinical tests may not adequately assess immunomodulator risks.
• Safety pharmacology testing and post-marketing surveillance are crucial.

Conclusions:

• Further research into immunomodulation toxicity is needed.
• Improved preclinical safety assessments are required for immunomodulators.
• Enhanced understanding of mechanisms will improve drug safety.